May 13, 2026
| Trial | ROAD |
|---|---|
| Cancer Type | Prostate Cancer |
| Hospital(s) | Belfast City Hospital |
| Information | Real-World Outcomes of DArolutamide, ADT, with or without Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer |
| Trial Open | Yes |
 |
Click Here to view trial summary |